ROIVANT SOCIAL VENTURES INC: Form 990, tax year 2023
View the entire original 990 at ProPublica ↗
- Organization
- ROIVANT SOCIAL VENTURES INC (EIN 83-3947490)
- Tax period
- 2023-04-01 to 2024-03-31
- Filed
- 2025-02-17
- IRS object ID
- 202530489349301243
- Schema version
- 2023v6.0
- Source
- Download XML · Original 990 at ProPublica
Every field in the e-filed return. Faint text is the IRS element name, for citing.
Return header ReturnHeader
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return | 2025-02-17T11:32:41-06:00 | ReturnTs |
| Tax Period End | 2024-03-31 | TaxPeriodEndDt |
Preparer Firm PreparerFirmGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Preparer Firm EIN | 871353108 | PreparerFirmEIN |
Preparer Firm Name PreparerFirmName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | EISNER ADVISORY GROUP LLC | BusinessNameLine1Txt |
Preparer US Address PreparerUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 733 THIRD AVENUE | AddressLine1Txt |
| City | NEW YORK | CityNm |
| State Abbreviation | NY | StateAbbreviationCd |
| ZIP | 100172703 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return Type | 990 | ReturnTypeCd |
| Tax Period Begin | 2023-04-01 | TaxPeriodBeginDt |
Filer Filer
| Field | Value | IRS element (for citing) |
|---|---|---|
| EIN | 833947490 | EIN |
Business Name BusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | ROIVANT SOCIAL VENTURES INC | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Control | ROIV | BusinessNameControlTxt |
| Phone | 2128476204 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 151 WEST 42ND STREET 15TH FLOOR | AddressLine1Txt |
| City | NEW YORK | CityNm |
| State Abbreviation | NY | StateAbbreviationCd |
| ZIP | 10036 | ZIPCd |
Business Officer BusinessOfficerGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person | LINDSAY ANDROSKI | PersonNm |
| Person Title | PRESIDENT AND CEO | PersonTitleTxt |
| Phone | 9146349551 | PhoneNum |
| Signature | 2025-02-17 | SignatureDt |
| Discuss With Paid Preparer | Yes (1) | DiscussWithPaidPreparerInd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| IRS Responsible Prty Info Curr | Yes (1) | IRSResponsiblePrtyInfoCurrInd |
Preparer Person PreparerPersonGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Preparer Person | CANDICE METH | PreparerPersonNm |
| PTIN | P01306891 | PTIN |
| Phone | 2129498700 | PhoneNum |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Tax | 2023 | TaxYr |
| Build TS | 2025-03-06 01:10:19Z | BuildTS |
Form 990 IRS990
| Field | Value | IRS element (for citing) |
|---|---|---|
| Principal Officer | LINDSAY ANDROSKI | PrincipalOfficerNm |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 151 WEST 42ND STREET 15TH FLOOR | AddressLine1Txt |
| City | NEW YORK | CityNm |
| State Abbreviation | NY | StateAbbreviationCd |
| ZIP | 10036 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Gross Receipts | $123,893 | GrossReceiptsAmt |
| Group Return For Affiliates | 0 | GroupReturnForAffiliatesInd |
| Organization501c3 | Yes (X) | Organization501c3Ind |
| Website Address | WWW.ROIVANTSV.ORG | WebsiteAddressTxt |
| Type Of Organization Corp | Yes (X) | TypeOfOrganizationCorpInd |
| Formation | 2018 | FormationYr |
| Legal Domicile State | DE | LegalDomicileStateCd |
| Activity Or Mission | PROMOTE SYSTEMIC, SUSTAINED IMPROVEMENTS TO THE WAY HEALTHCARE IS ACCESSED AND DELIVERED. | ActivityOrMissionDesc |
| Voting Members Governing Body | 5 | VotingMembersGoverningBodyCnt |
| Voting Members Independent | 0 | VotingMembersIndependentCnt |
| Total Employee | 0 | TotalEmployeeCnt |
| Total Volunteers | 41 | TotalVolunteersCnt |
| Total Gross UBI | $0 | TotalGrossUBIAmt |
| Net Unrelated Bus Txbl Incm | $0 | NetUnrelatedBusTxblIncmAmt |
| PY Contributions Grants | $170,136 | PYContributionsGrantsAmt |
| CY Contributions Grants | $110,143 | CYContributionsGrantsAmt |
| PY Program Service Revenue | $0 | PYProgramServiceRevenueAmt |
| CY Program Service Revenue | $0 | CYProgramServiceRevenueAmt |
| PY Investment Income | $12,957 | PYInvestmentIncomeAmt |
| CY Investment Income | $13,750 | CYInvestmentIncomeAmt |
| PY Other Revenue | $0 | PYOtherRevenueAmt |
| CY Other Revenue | $0 | CYOtherRevenueAmt |
| PY Total Revenue | $183,093 | PYTotalRevenueAmt |
| CY Total Revenue | $123,893 | CYTotalRevenueAmt |
| PY Grants And Similar Paid | $0 | PYGrantsAndSimilarPaidAmt |
| CY Grants And Similar Paid | $0 | CYGrantsAndSimilarPaidAmt |
| PY Benefits Paid To Members | $0 | PYBenefitsPaidToMembersAmt |
| CY Benefits Paid To Members | $0 | CYBenefitsPaidToMembersAmt |
| PY Salaries Comp Emp Bnft Paid | $0 | PYSalariesCompEmpBnftPaidAmt |
| CY Salaries Comp Emp Bnft Paid | $0 | CYSalariesCompEmpBnftPaidAmt |
| PY Total Prof Fndrsng Expns | $0 | PYTotalProfFndrsngExpnsAmt |
| CY Total Prof Fndrsng Expns | $0 | CYTotalProfFndrsngExpnsAmt |
| CY Total Fundraising Expense | $43,632 | CYTotalFundraisingExpenseAmt |
| PY Other Expenses | $245,560 | PYOtherExpensesAmt |
| CY Other Expenses | $254,637 | CYOtherExpensesAmt |
| PY Total Expenses | $245,560 | PYTotalExpensesAmt |
| CY Total Expenses | $254,637 | CYTotalExpensesAmt |
| PY Revenues Less Expenses | -$62,467 | PYRevenuesLessExpensesAmt |
| CY Revenues Less Expenses | -$130,744 | CYRevenuesLessExpensesAmt |
| Total Assets BOY | $755,918 | TotalAssetsBOYAmt |
| Total Assets EOY | $627,351 | TotalAssetsEOYAmt |
| Total Liabilities BOY | $256,627 | TotalLiabilitiesBOYAmt |
| Total Liabilities EOY | $258,804 | TotalLiabilitiesEOYAmt |
| Net Assets Or Fund Balances BOY | $499,291 | NetAssetsOrFundBalancesBOYAmt |
| Net Assets Or Fund Balances EOY | $368,547 | NetAssetsOrFundBalancesEOYAmt |
| Info In Schedule O Part III | Yes (X) | InfoInScheduleOPartIIIInd |
| Mission | SEE SCHEDULE OOUR MISSION IS TO IMPROVE EQUITY IN HEALTH CARE ACCESS AND OUTCOMES ACROSS GEOGRAPHIES, SOCIOECONOMICS, AND DEMOGRAPHICS ON A NOT-FOR-PROFIT, CHARITABLE BASIS. WE USE INNOVATIONS IN SCIENCE AND TECHNOLOGY TO CHALLENGE AND ADVANCE THE NORMS OF BIOPHARMA AND HEALTH CARE DELIVERY. OUR WORK IS ACROSS TWO STRATEGIES: (I) INVESTMENTS AND INCUBATION LEADERSHIP TO EARLY-STAGE INNOVATIVE HEALTH ACCESS, MANUFACTURING, AND DRUG DEVELOPMENT ORGANIZATIONS WITH NO OR LOW-COST "PATIENT" CAPITAL AND RESOURCES; (II) CHARITABLE PARTNERSHIPS AND EDUCATIONAL INITIATIVES ACROSS INDUSTRY, PATIENT ADVOCACY, AND INVESTORS ACCELERATING DEVELOPMENT OF NEW MEDICINES. | MissionDesc |
| Significant New Program Srvc | 0 | SignificantNewProgramSrvcInd |
| Significant Change | 0 | SignificantChangeInd |
| Expense | $124,537 | ExpenseAmt |
| Desc | SEE SCHEDULE OTHE ORGANIZATION HAD THE FOLLOWING INITIATIVES FOR THE FISCAL-YEARENDING MARCH 31, 2024:(I) TEACHING ROIVANT SOCIAL VENTURES "MAKING MEDICINES" COURSE AT THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL'S ESHELMAN SCHOOL OF PHARMACY, THE NUMBER ONE RANKED PHARMACY SCHOOL IN THE UNITED STATES. WE DESIGNED THIS INNOVATIVE COURSE TO INTRODUCE PHARMD STUDENTS TO THE NEW DRUG APPROVAL PROCESS AND KEY ISSUES IN DRUG DISCOVERY, PRE-CLINICAL TESTING, CLINICAL TRIALS, FDA APPROVAL, AND GLOBAL ACCESS TO MEDICINES. THE COURSE WAS IN HIGH DEMAND AND RECEIVED MULTIPLE TEACHING AWARDS IN 2023.(II) LAUNCHING ROIVANT SOCIAL VENTURES' INAUGURAL ACCESS TO MEDICINES PHARMA INTERNSHIPS FOR TALENTED PHARMD STUDENTS FROM GROUPS WITH DISPROPORTIONATE UNMET NEEDS IN MEDICINE. IN ITS FIRST YEAR THE PROGRAM PROVIDED REAL-WORLD DRUG DEVELOPMENT EXPERIENCE TO FOUR HIGHLY QUALIFIED PHARMD STUDENTS.(III) CONTINUING OUR THOUGHT LEADERSHIP CAMPAIGN THROUGH SPEAKING AT EVENTS WITH THE TERMEER FOUNDATION, BIO'S CEO AND INVESTOR CONFERENCE, THE ADVANCING WOMEN'S LEADERSHIP IN PHARMA AND HEALTHCARE CONFERENCE, NATIONAL VACCINE LAW CONFERENCE, AND 50/50 WOMEN ON BOARDS.(IV) ADVANCING OUR MISSION, AS HIGHLIGHTED BY PUBLICATIONS SUCH AS "THINKING AHEAD: DEVELOPING BIOSYNTHETIC BLOOD TO ANTICIPATE DONOR DROUGHT" IN CELL & GENE THERAPY INSIGHTS, "FEEDER PROGRAMS FIRST STEP IN BRINGING MORE DIVERSITY TO PHARMA" IN BIOSPACE, AND "THE REMAKING OF "MAKING MEDICINES" BY CAROLINA PHARMACY. (V) INCUBATING THE BRIDGE DIRECTORY, WHERE WE EMBEDDED ROIVANT EMPLOYEE VOLUNTEERS TO ASSIST THEM IN BUILDING OUT THE NEXT ITERATION OF THEIR WEBSITE, DEVISED A DIGITAL ADVERTISING STRATEGY TO PROMOTE GROWTH OF THEIR MISSION AND BRAND, AND DEVELOPED A STRATEGY LEVERAGING DATA ANALYTICS TO BUILD IMPACTFUL DATA TRACKING INITIATIVES. | Desc |
| Total Program Service Expenses | $124,537 | TotalProgramServiceExpensesAmt |
| Described In Section501c3 | Yes (1) | DescribedInSection501c3Ind |
| Schedule B Required | Yes (1) | ScheduleBRequiredInd |
| Political Campaign Acty | 0 | PoliticalCampaignActyInd |
| Lobbying Activities | 0 | LobbyingActivitiesInd |
| Subject To Proxy Tax | 0 | SubjectToProxyTaxInd |
| Donor Advised Fund | 0 | DonorAdvisedFundInd |
| Conservation Easements | 0 | ConservationEasementsInd |
| Collections Of Art | 0 | CollectionsOfArtInd |
| Credit Counseling | 0 | CreditCounselingInd |
| Donor Rstr Or Quasi Endowments | 0 | DonorRstrOrQuasiEndowmentsInd |
| Report Land Building Equipment | 0 | ReportLandBuildingEquipmentInd |
| Report Investments Other Sec | 0 | ReportInvestmentsOtherSecInd |
| Report Program Related Invst | Yes (1) | ReportProgramRelatedInvstInd |
| Report Other Assets | 0 | ReportOtherAssetsInd |
| Report Other Liabilities | 0 | ReportOtherLiabilitiesInd |
| Include FIN48 Footnote | 0 | IncludeFIN48FootnoteInd |
| Independent Audit Fincl Stmt | 0 | IndependentAuditFinclStmtInd |
| Consolidated Audit Fincl Stmt | 0 | ConsolidatedAuditFinclStmtInd |
| School Operating | 0 | SchoolOperatingInd |
| Foreign Office | 0 | ForeignOfficeInd |
| Foreign Activities | 0 | ForeignActivitiesInd |
| More Than5000 K To Org | 0 | MoreThan5000KToOrgInd |
| More Than5000 K To Individuals | 0 | MoreThan5000KToIndividualsInd |
| Professional Fundraising | 0 | ProfessionalFundraisingInd |
| Fundraising Activities | 0 | FundraisingActivitiesInd |
| Gaming Activities | 0 | GamingActivitiesInd |
| Operate Hospital | 0 | OperateHospitalInd |
| Grants To Organizations | 0 | GrantsToOrganizationsInd |
| Grants To Individuals | 0 | GrantsToIndividualsInd |
| Schedule J Required | Yes (1) | ScheduleJRequiredInd |
| Tax Exempt Bonds | 0 | TaxExemptBondsInd |
| Engaged In Excess Benefit Trans | 0 | EngagedInExcessBenefitTransInd |
| PY Excess Benefit Trans | 0 | PYExcessBenefitTransInd |
| Loan Outstanding | Yes (1) | LoanOutstandingInd |
| Grant To Related Person | 0 | GrantToRelatedPersonInd |
| Business Rln With Org Mem | 0 | BusinessRlnWithOrgMemInd |
| Business Rln With Fam Mem | 0 | BusinessRlnWithFamMemInd |
| Business Rln With35 Ctrl Ent | 0 | BusinessRlnWith35CtrlEntInd |
| Deductible Non Cash Contri | 0 | DeductibleNonCashContriInd |
| Deductible Art Contribution | 0 | DeductibleArtContributionInd |
| Terminate Operations | 0 | TerminateOperationsInd |
| Partial Liquidation | 0 | PartialLiquidationInd |
| Disregarded Entity | 0 | DisregardedEntityInd |
| Related Entity | Yes (1) | RelatedEntityInd |
| Related Organization Ctrl Ent | 0 | RelatedOrganizationCtrlEntInd |
| Trnsfr Exmpt Non Chrtbl Rltd Org | 0 | TrnsfrExmptNonChrtblRltdOrgInd |
| Activities Conducted Prtshp | 0 | ActivitiesConductedPrtshpInd |
| Schedule O Required | Yes (1) | ScheduleORequiredInd |
| IRP Document | 10 | IRPDocumentCnt |
| IRP Document W2 G | 0 | IRPDocumentW2GCnt |
| Backup Wthld Compliance | Yes (1) | BackupWthldComplianceInd |
| Employee | 0 | EmployeeCnt |
| Unrelated Bus Incm Over Limit | 0 | UnrelatedBusIncmOverLimitInd |
| Foreign Financial Account | 0 | ForeignFinancialAccountInd |
| Prohibited Tax Shelter Trans | 0 | ProhibitedTaxShelterTransInd |
| Taxable Party Notification | 0 | TaxablePartyNotificationInd |
| Nondeductible Contributions | 0 | NondeductibleContributionsInd |
| Quid Pro Quo Contributions | 0 | QuidProQuoContributionsInd |
| Form8282 Property Disposed Of | 0 | Form8282PropertyDisposedOfInd |
| Rcv Fnds To Pay Prsnl Bnft Cntrct | 0 | RcvFndsToPayPrsnlBnftCntrctInd |
| Pay Premiums Prsnl Bnft Cntrct | 0 | PayPremiumsPrsnlBnftCntrctInd |
| Indoor Tanning Services | 0 | IndoorTanningServicesInd |
| Subj To Tax Rmnrtn Ex Prcht Pymt | 0 | SubjToTaxRmnrtnExPrchtPymtInd |
| Subject To Excs Tax Net Invst Inc | 0 | SubjectToExcsTaxNetInvstIncInd |
| Info In Schedule O Part VI | Yes (X) | InfoInScheduleOPartVIInd |
| Governing Body Voting Members | 5 | GoverningBodyVotingMembersCnt |
| Independent Voting Member | 0 | IndependentVotingMemberCnt |
| Family Or Business Rln | Yes (1) | FamilyOrBusinessRlnInd |
| Delegation Of Mgmt Duties | 0 | DelegationOfMgmtDutiesInd |
| Change To Org Documents | 0 | ChangeToOrgDocumentsInd |
| Material Diversion Or Misuse | 0 | MaterialDiversionOrMisuseInd |
| Members Or Stockholders | Yes (1) | MembersOrStockholdersInd |
| Election Of Board Members | Yes (1) | ElectionOfBoardMembersInd |
| Decisions Subject To Approva | 0 | DecisionsSubjectToApprovaInd |
| Minutes Of Governing Body | Yes (1) | MinutesOfGoverningBodyInd |
| Minutes Of Committees | 0 | MinutesOfCommitteesInd |
| Officer Mailing Address | 0 | OfficerMailingAddressInd |
| Local Chapters | 0 | LocalChaptersInd |
| Form990 Provided To Gvrn Body | Yes (1) | Form990ProvidedToGvrnBodyInd |
| Conflict Of Interest Policy | Yes (1) | ConflictOfInterestPolicyInd |
| Annual Disclosure Covered Prsn | Yes (1) | AnnualDisclosureCoveredPrsnInd |
| Regular Monitoring Enfrc | Yes (1) | RegularMonitoringEnfrcInd |
| Whistleblower Policy | Yes (1) | WhistleblowerPolicyInd |
| Document Retention Policy | Yes (1) | DocumentRetentionPolicyInd |
| Compensation Process CEO | 0 | CompensationProcessCEOInd |
| Compensation Process Other | 0 | CompensationProcessOtherInd |
| Investment In Joint Venture | 0 | InvestmentInJointVentureInd |
| States Where Copy Of Return Is Fld | NY | StatesWhereCopyOfReturnIsFldCd |
| Upon Request | Yes (X) | UponRequestInd |
Books In Care Of Detail BooksInCareOfDetail
Business Name BusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | AMANDA WALDHAUSER | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Phone | 8472091020 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 151 WEST 42ND STREET 15TH FLOOR | AddressLine1Txt |
| City | NEW YORK | CityNm |
| State Abbreviation | NY | StateAbbreviationCd |
| ZIP | 10036 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Info In Schedule O Part VII | Yes (X) | InfoInScheduleOPartVIIInd |
Form990 Part VII Section A Form990PartVIISectionAGrp (5 entries)
| TitleTitleTxt | Average Hours Per WeekAverageHoursPerWeekRt | Average Hours Per Week Rltd OrgAverageHoursPerWeekRltdOrgRt | Individual Trustee Or DirectorIndividualTrusteeOrDirectorInd | OfficerOfficerInd | Reportable Comp From OrgReportableCompFromOrgAmt | Reportable Comp From Rltd OrgReportableCompFromRltdOrgAmt | Other CompensationOtherCompensationAmt |
|---|---|---|---|---|---|---|---|
| ERIC VENKER | |||||||
| DIRECTOR AND CHAIR | 0.20 | 49.80 | Yes (X) | Yes (X) | $0 | $30,854,317 | $21,874 |
| MATTHEW GLINE | |||||||
| DIRECTOR AND SECRETARY | 0.20 | 49.80 | Yes (X) | Yes (X) | $0 | $5,808,808 | $33,138 |
| RAKHI KUMAR | |||||||
| DIRECTOR AND TREASURER | 0.20 | 49.80 | Yes (X) | Yes (X) | $0 | $4,715,239 | $2,285,161 |
| DANIEL PATTERSON | |||||||
| DIRECTOR | 0.20 | 49.80 | Yes (X) | $0 | $1,933,271 | $8,651 | |
| LINDSAY ANDROSKI | |||||||
| DIRECTOR, PRESIDENT AND CEO | 4.00 | 46.00 | Yes (X) | Yes (X) | $0 | $1,020,489 | $298,442 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Reportable Comp From Org | $0 | TotalReportableCompFromOrgAmt |
| Tot Reportable Comp Rltd Org | $44,332,124 | TotReportableCompRltdOrgAmt |
| Total Other Compensation | $2,647,266 | TotalOtherCompensationAmt |
| Indiv Rcvd Greater Than100 K | 0 | IndivRcvdGreaterThan100KCnt |
| Former Ofcr Employees Listed | 0 | FormerOfcrEmployeesListedInd |
| Total Comp Greater Than150 K | Yes (1) | TotalCompGreaterThan150KInd |
| Compensation From Other Srcs | 0 | CompensationFromOtherSrcsInd |
| Cntrct Rcvd Greater Than100 K | 0 | CntrctRcvdGreaterThan100KCnt |
| All Other Contributions | $110,143 | AllOtherContributionsAmt |
| Total Contributions | $110,143 | TotalContributionsAmt |
Investment Income InvestmentIncomeGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $13,750 | TotalRevenueColumnAmt |
| Exclusion | $13,750 | ExclusionAmt |
Total Revenue TotalRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $123,893 | TotalRevenueColumnAmt |
| Related Or Exempt Func Income | $0 | RelatedOrExemptFuncIncomeAmt |
| Unrelated Business Revenue | $0 | UnrelatedBusinessRevenueAmt |
| Exclusion | $13,750 | ExclusionAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Info In Schedule O Part IX | Yes (X) | InfoInScheduleOPartIXInd |
Fees For Services Management FeesForServicesManagementGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $127,051 | TotalAmt |
| Program Services | $80,254 | ProgramServicesAmt |
| Management And General | $27,350 | ManagementAndGeneralAmt |
| Fundraising | $19,447 | FundraisingAmt |
Fees For Services Legal FeesForServicesLegalGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $345 | TotalAmt |
| Fundraising | $345 | FundraisingAmt |
Fees For Services Accounting FeesForServicesAccountingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $34,500 | TotalAmt |
| Management And General | $34,500 | ManagementAndGeneralAmt |
Fees For Services Other FeesForServicesOtherGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $51,288 | TotalAmt |
| Program Services | $32,397 | ProgramServicesAmt |
| Management And General | $11,041 | ManagementAndGeneralAmt |
| Fundraising | $7,850 | FundraisingAmt |
Travel TravelGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $7,851 | TotalAmt |
| Program Services | $7,851 | ProgramServicesAmt |
Conferences Meetings ConferencesMeetingsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $4,035 | TotalAmt |
| Program Services | $4,035 | ProgramServicesAmt |
Other Expenses OtherExpensesGrp (2 entries)
| DescDesc | TotalTotalAmt | FundraisingFundraisingAmt | Management And GeneralManagementAndGeneralAmt |
|---|---|---|---|
| PUBLICATION/SUBSCRIPT. | $15,990 | $15,990 | |
| FILING FEES | $13,577 | $13,577 |
Total Functional Expenses TotalFunctionalExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $254,637 | TotalAmt |
| Program Services | $124,537 | ProgramServicesAmt |
| Management And General | $86,468 | ManagementAndGeneralAmt |
| Fundraising | $43,632 | FundraisingAmt |
Cash Non Interest Bearing CashNonInterestBearingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $476,489 | BOYAmt |
| EOY | $337,602 | EOYAmt |
Accounts Receivable AccountsReceivableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $22,473 | BOYAmt |
| EOY | $36,224 | EOYAmt |
Investments Program Related InvestmentsProgramRelatedGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $250,000 | BOYAmt |
| EOY | $250,000 | EOYAmt |
Other Assets Total OtherAssetsTotalGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $6,956 | BOYAmt |
| EOY | $3,525 | EOYAmt |
Total Assets TotalAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $755,918 | BOYAmt |
| EOY | $627,351 | EOYAmt |
Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $6,627 | BOYAmt |
| EOY | $8,804 | EOYAmt |
Loans From Officers Directors LoansFromOfficersDirectorsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $250,000 | BOYAmt |
| EOY | $250,000 | EOYAmt |
Total Liabilities TotalLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $256,627 | BOYAmt |
| EOY | $258,804 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Organization Follows FASB117 | Yes (X) | OrganizationFollowsFASB117Ind |
No Donor Restriction Net Assets NoDonorRestrictionNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $499,291 | BOYAmt |
| EOY | $368,547 | EOYAmt |
Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $499,291 | BOYAmt |
| EOY | $368,547 | EOYAmt |
Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $755,918 | BOYAmt |
| EOY | $627,351 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Reconcilation Revenue Expnss | -$130,744 | ReconcilationRevenueExpnssAmt |
| Other Changes In Net Assets | $0 | OtherChangesInNetAssetsAmt |
| Method Of Accounting Accrual | Yes (X) | MethodOfAccountingAccrualInd |
| Accountant Compile Or Review | 0 | AccountantCompileOrReviewInd |
| FS Audited | 0 | FSAuditedInd |
| Federal Grant Audit Required | 0 | FederalGrantAuditRequiredInd |
Schedule A IRS990ScheduleA
| Field | Value | IRS element (for citing) |
|---|---|---|
| Public Organization170 | Yes (X) | PublicOrganization170Ind |
Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus3 Years | $23,041 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $684,276 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $170,136 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $110,143 | CurrentTaxYearAmt |
| Total | $987,596 | TotalAmt |
Total Calendar Year170 TotalCalendarYear170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus3 Years | $23,041 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $684,276 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $170,136 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $110,143 | CurrentTaxYearAmt |
| Total | $987,596 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Substantial Contributors Tot | $158,438 | SubstantialContributorsTotAmt |
| Public Support Total170 | $829,158 | PublicSupportTotal170Amt |
Gross Investment Income170 GrossInvestmentIncome170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus2 Years | $9,516 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $12,957 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $13,750 | CurrentTaxYearAmt |
| Total | $36,223 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Support | $1,023,819 | TotalSupportAmt |
| Public Support CY170 | 0.80990 | PublicSupportCY170Pct |
| Public Support PY170 | 0.84150 | PublicSupportPY170Pct |
| Thirty Thr Pct Suprt Tests CY170 | Yes (X) | ThirtyThrPctSuprtTestsCY170Ind |
Schedule B IRS990ScheduleB
Contributor Information ContributorInformationGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Contributor | RESTRICTED | ContributorNum |
Contributor Business Name ContributorBusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | RESTRICTED | BusinessNameLine1 |
Contributor US Address ContributorUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | RESTRICTED | AddressLine1 |
| Address Line2 | RESTRICTED | AddressLine2 |
| City | RESTRICTED | City |
| State | RESTRICTED | State |
| ZIP Code | RESTRICTED | ZIPCode |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Contributions | RESTRICTED | TotalContributionsAmt |
Schedule D IRS990ScheduleD
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Book Value Land Buildings | $0 | TotalBookValueLandBuildingsAmt |
Invst Program Related Org InvstProgramRelatedOrgGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Desc | PROGRAM RELATED LOAN RECEIVABLE | Desc |
| Book Value | $250,000 | BookValueAmt |
| Method Valuation | F | MethodValuationCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Book Value Program Rltd | $250,000 | TotalBookValueProgramRltdAmt |
Schedule J IRS990ScheduleJ
| Field | Value | IRS element (for citing) |
|---|---|---|
| Severance Payment | 0 | SeverancePaymentInd |
| Supplemental Nonqual Rtr Plan | 0 | SupplementalNonqualRtrPlanInd |
| Equity Based Comp Arrngm | Yes (1) | EquityBasedCompArrngmInd |
| Comp Based On Revenue Of Flng Org | 0 | CompBasedOnRevenueOfFlngOrgInd |
| Comp Bsd On Rev Related Orgs | 0 | CompBsdOnRevRelatedOrgsInd |
| Comp Bsd Net Earns Flng Org | 0 | CompBsdNetEarnsFlngOrgInd |
| Comp Bsd Net Earns Rltd Orgs | 0 | CompBsdNetEarnsRltdOrgsInd |
| Any Non Fixed Payments | 0 | AnyNonFixedPaymentsInd |
| Initial Contract Exception | 0 | InitialContractExceptionInd |
Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (5 entries)
| TitleTitleTxt | Base Compensation Filing OrgBaseCompensationFilingOrgAmt | Compensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmt | Bonus Filing OrganizationBonusFilingOrganizationAmount | Bonus Related OrganizationsBonusRelatedOrganizationsAmt | Other Compensation Filing OrgOtherCompensationFilingOrgAmt | Other Compensation Rltd OrgsOtherCompensationRltdOrgsAmt | Deferred Compensation Flng OrgDeferredCompensationFlngOrgAmt | Deferred Comp Rltd OrgsDeferredCompRltdOrgsAmt | Nontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmt | Nontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmt | Total Compensation Filing OrgTotalCompensationFilingOrgAmt | Total Compensation Rltd OrgsTotalCompensationRltdOrgsAmt | Comp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmt | Comp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ERIC VENKER | ||||||||||||||
| DIRECTOR AND CHAIR | $0 | $557,306 | $0 | $637,630 | $0 | $29,659,381 | $0 | $0 | $0 | $21,874 | $0 | $30,876,191 | $0 | $26,340,289 |
| RAKHI KUMAR | ||||||||||||||
| DIRECTOR AND TREASURER | $0 | $368,750 | $0 | $500,500 | $0 | $3,845,989 | $0 | $2,285,161 | $0 | $0 | $0 | $7,000,400 | $0 | $1,170,312 |
| MATTHEW GLINE | ||||||||||||||
| DIRECTOR AND SECRETARY | $0 | $725,000 | $0 | $1,036,750 | $0 | $4,047,058 | $0 | $0 | $0 | $33,138 | $0 | $5,841,946 | $0 | $0 |
| DANIEL PATTERSON | ||||||||||||||
| DIRECTOR | $0 | $251,377 | $0 | $96,363 | $0 | $1,585,531 | $0 | $0 | $0 | $8,651 | $0 | $1,941,922 | $0 | $170,797 |
| LINDSAY ANDROSKI | ||||||||||||||
| DIRECTOR, PRESIDENT AND CEO | $0 | $305,625 | $0 | $315,000 | $0 | $399,864 | $0 | $279,550 | $0 | $18,892 | $0 | $1,318,931 | $0 | $56,942 |
Supplemental Information Detail SupplementalInformationDetail (2 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| PART I, LINE 3: | NO OFFICER IS COMPENSATED BY THE ORGANIZATION. |
| PART I, LINES 4B-C | WHILE NO OFFICER IS COMPENSATED BY THE FILING ENTITY, OFFICERS HAVE BEEN COMPENSATED FOR THEIR WORK FOR A RELATED ENTITY THAT IS CONSIDERED A BROTHER/SISTER TO THE FILING ENTITY. THE RELATED ENTITY HAS BOTH A SUPPLEMENTAL NONQUALIFIED RETIREMENT PLAN AND EQUITY BASED COMPENSATION ARRANGEMENT FOR ITS EMPLOYEES, AS HAS BEEN DISCLOSED IN PART II. |
Schedule L IRS990ScheduleL
Loans Btwn Org Interested Prsn LoansBtwnOrgInterestedPrsnGrp
Business Name BusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | ROIVANT SCIENCES LTD | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Relationship With Org | CREATOR | RelationshipWithOrgTxt |
| Loan Purpose | TO ENABLE RSV TO FUND A LOAN TO AN UNRELATED ENTITY TO SUPPORT ITS PROGRAM | LoanPurposeTxt |
| Loan To Organization | Yes (X) | LoanToOrganizationInd |
| Original Principal | $250,000 | OriginalPrincipalAmt |
| Balance Due | $250,000 | BalanceDueAmt |
| Default | 0 | DefaultInd |
| Board Or Committee Approval | Yes (1) | BoardOrCommitteeApprovalInd |
| Written Agreement | Yes (1) | WrittenAgreementInd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Balance Due | $250,000 | TotalBalanceDueAmt |
Schedule O IRS990ScheduleO
Supplemental Information Detail SupplementalInformationDetail (10 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| FORM 990, PART VI, SECTION A, LINE 2 | EACH OF THE OFFICERS AND DIRECTORS ARE EMPLOYED BY ROIVANT SCIENCES INC. A WHOLLY CONTROLLED ENTITY OF ROIVANT SCIENCES LTD., ROIVANT SOCIAL VENTURES, INC'S (THE ORGANIZATION") SOLE MEMBER. |
| FORM 990, PART VI, SECTION A, LINE 6 | ROIVANT SOCIAL VENTURES, INC. HAS A SOLE MEMBER ROIVANT SCIENCES LTD. |
| FORM 990, PART VI, SECTION A, LINE 7A | AS THE SOLE MEMBER, ROIVANT SCIENCES LTD. HAS THE RIGHT TO (I) APPROVE THE ELECTION OF DIRECTORS; (II) APPROVE THE NUMBER OF DIRECTORS COMPRISING THE BOARD OF DIRECTORS; (III) REMOVE DIRECTORS WITH OR WITHOUT CAUSE; (IV) APPROVE ANY AMENDMENT TO THE CERTIFICATE OF INCORPORATION OR BYLAWS OF THE CORPORATION ADOPTED BY THE BOARD OF DIRECTORS; (V) APPROVE THE MERGER, SALE OF ALL OR SUBSTANTIALLY ALL OF THE ASSETS, DOMESTICATION, CONVERSION OR DISSOLUTION OF THE CORPORATION, IN EACH CASE AS ADOPTED BY THE BOARD OF DIRECTORS; AND (VI) VOTE FOR SUCH OTHER MATTERS AS MAY BE PROVIDED IN THESE BYLAWS OR THE PROVISIONS OF THE DELAWARE GENERAL CORPORATION LAW. |
| FORM 990, PART VI, SECTION A, LINE 8B | GIVEN THE SIZE OF THE ORGANIZATION'S BOARD OF DIRECTORS, THERE ARE NO FORMAL COMMITTEES. |
| FORM 990, PART VI, SECTION B, LINE 11B | THE FORM 990 IS REVIEWED AND APPROVED BY THE ORGANIZATION'S PRESIDENT AND CEO PRIOR TO FILING. THE BOARD OF DIRECTORS ARE PROVIDED A COPY OF THE 990 PRIOR TO FILING. |
| FORM 990, PART VI, SECTION B, LINE 12C | ALL BOARD MEMBERS ARE REQUIRED TO REVIEW AND SIGN A CONFLICT-OF-INTEREST DOCUMENT AND CONFORM WITH THE ORGANIZATION'S POLICY WHICH IS REGULARLY MONITORED AND ENFORCED FOR COMPLIANCE. |
| FORM 990, PART VI, SECTION B, LINE 15 | THE ORGANIZATION HAS NO EMPLOYEES. |
| FORM 990, PART VI, SECTION C, LINE 19 | THE ORGANIZATION'S FINANCIAL STATEMENTS AND FORM 990 ARE AVAILABLE UPON REQUEST. THE ORGANIZATION'S GOVERNING DOCUMENTS AND CONFLICT OF INTEREST POLICY ARE NOT OPEN FOR PUBLIC INSPECTION. |
| FORM 990, PART VII | EACH OF THE OFFICERS AND DIRECTORS ARE EMPLOYED BY ROIVANT SCIENCES INC., AND AS SUCH THE COMPENSATION LISTED IN PART VII FROM THE RELATED ENTITY REPRESENTS AMOUNTS PAID TO THE LISTED OFFICERS AND DIRECTORS OF THE ORGANIZATION SOLELY FOR THE SERVICES PROVIDED TO ROIVANT SCIENCES INC.. NO OFFICER OR DIRECTOR IS COMPENSATED BY THE ORGANIZATION. |
| FORM 990, PART IX, LINE 11G | MANAGEMENT CONSULTING SERVICES: PROGRAM SERVICE EXPENSES 32,397. MANAGEMENT AND GENERAL EXPENSES 11,041. FUNDRAISING EXPENSES 7,850. TOTAL EXPENSES 51,288. |
Schedule R IRS990ScheduleR
Id Related Org Txbl Corp Tr IdRelatedOrgTxblCorpTrGrp (108 entries)
| Address Line1ForeignAddress/AddressLine1Txt | CityForeignAddress/CityNm | CountryForeignAddress/CountryCd | Foreign PostalForeignAddress/ForeignPostalCd | EINEIN | Primary ActivitiesPrimaryActivitiesTxt | Legal Domicile Foreign CountryLegalDomicileForeignCountryCd | Business Name Line1DirectControllingEntityName/BusinessNameLine1Txt | Entity TypeEntityTypeTxt | Controlled OrganizationControlledOrganizationInd | Address Line1USAddress/AddressLine1Txt | CityUSAddress/CityNm | State AbbreviationUSAddress/StateAbbreviationCd | ZIPUSAddress/ZIPCd | Legal Domicile StateLegalDomicileStateCd | Province Or StateForeignAddress/ProvinceOrStateNm | Direct Controlling NADirectControllingNACd |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AFFIVANT SCIENCES GMBH | ||||||||||||||||
| VIADUKTSTRASSE 8 | BASEL | SZ | 4051 | 981565911 | SCIENTIFIC R&D | SZ | AFFIVANT SCIENCES HOLDINGS LIMITED | C | 0 | |||||||
| AFFIVANT SCIENCES HOLDINGS LIMITED | ||||||||||||||||
| 7TH FL 50 BROADWAY | LONDON | UK | SW1H 0DB | 981565694 | HOLDING COMPANY | UK | AFFIVANT SCIENCES LTD | C | 0 | |||||||
| AFFIVANT SCIENCES LTD | ||||||||||||||||
| 7TH FL 50 BROADWAY | LONDON | UK | SW1H 0DB | 981565414 | HOLDING COMPANY | BD | ROIVANT SCIENCES LTD | C | 0 | |||||||
| AFFIVANT SCIENCES INC | ||||||||||||||||
| 853594557 | SCIENTIFIC R&D | AFFIVANT SCIENCES HOLDINGS LIMITED | C | 0 | 151 W 42ND ST | NEW YORK | NY | 10036 | DE | |||||||
| ALYVANT GMBH | ||||||||||||||||
| VIADUKTSTRASSE 8 | BASEL | SZ | 4051 | 981463962 | SCIENTIFIC R&D | SZ | ALYVANT HOLDINGS LIMITED | C | 0 | |||||||
| ALYVANT HOLDINGS LIMITED | ||||||||||||||||
| 7TH FL 50 BROADWAY | LONDON | UK | SW1H 0DB | HOLDING COMPANY | UK | ALYVANT LTD | C | 0 | ||||||||
| ALYVANT LTD | ||||||||||||||||
| 7TH FL 50 BROADWAY | LONDON | UK | SW1H 0DB | 981494184 | HOLDING COMPANY | BD | ROIVANT SCIENCES LTD | C | 0 | |||||||
| ARUVANT SCIENCES GMBH | ||||||||||||||||
| VIADUKTSTRASSE 8 | BASEL | SZ | 4051 | SCIENTIFIC R&D | SZ | ARUVANT SCIENCES HOLDINGS LTD | C | 0 | ||||||||
| ARUVANT SCIENCES HOLDINGS LTD | ||||||||||||||||
| 7TH FL 50 BROADWAY | LONDON | UK | SW1H 0DB | 981466915 | HOLDING COMPANY | UK | ARUVANT SCIENCES LTD | C | 0 | |||||||
| ARUVANT SCIENCES LTD | ||||||||||||||||
| 7TH FL 50 BROADWAY | LONDON | UK | SW1H 0DB | 981490198 | HOLDING COMPANY | BD | ROIVANT SCIENCES LTD | C | 0 | |||||||
| ARUVANT SCIENCES INC | ||||||||||||||||
| 831984915 | SCIENTIFIC R&D | ARUVANT SCIENCES HOLDINGS LTD | C | 0 | 151 W 42ND ST | NEW YORK | NY | 10036 | DE | |||||||
| COVANT THERAPEUTICS OPERATING INC | ||||||||||||||||
| 922630605 | SCIENTIFIC R&D | ROIVANT DISCOVERY INC | C | 0 | 451 D STREET BOSTON MA 02210 | BOSTON | MA | 02210 | DE | |||||||
| DERMAVANT HOLDINGS LIMITED | ||||||||||||||||
| 7TH FL 50 BROADWAY | LONDON | UK | SW1H 0DB | 981468969 | HOLDING COMPANY | UK | DERMAVANT SCIENCES LTD | C | 0 | |||||||
| DERMAVANT SCIENCES GMBH | ||||||||||||||||
| VIADUKTSTRASSE 8 | BASEL | SZ | 4051 | SCIENTIFIC R&D | SZ | DERMAVANT HOLDINGS LIMITED | C | 0 | ||||||||
| DERMAVANT SCIENCES IRL LIMITED | ||||||||||||||||
| ROCKTWIST HOUSE BLOCK 1 WESTERN BU | CLARE | EI | V14 FW97 | SCIENTIFIC R&D | EI | DERMAVANT HOLDINGS LIMITED | C | 0 | CLARE | |||||||
| DERMAVANT SCIENCES LTD | ||||||||||||||||
| 7TH FL 50 BROADWAY | LONDON | UK | SW1H 0DB | 981465533 | HOLDING COMPANY | BD | ROIVANT SCIENCES LTD | C | 0 | |||||||
| DERMAVANT SCIENCES INC | ||||||||||||||||
| 364835813 | SCIENTIFIC R&D | DERMAVANT HOLDINGS LIMITED | C | 0 | 3780 KILROY AIRPORT WAY STE 250 | LONG BEACH | CA | 90806 | DE | |||||||
| DSL TREASURY HOLDINGS INC | ||||||||||||||||
| 852075395 | HOLDING COMPANY | DERMAVANT SCIENCES LTD | C | 0 | 3780 KILROY AIRPORT WAY STE 250 | LONG BEACH | CA | 90806 | DE | |||||||
| DSL TREASURY INC | ||||||||||||||||
| 852103069 | HOLDING COMPANY | DSL TREASURY HOLDINGS INC | C | 0 | 3780 KILROY AIRPORT WAY STE 250 | LON | CA | 90806 | DE | |||||||
| EMAVANT SOLUTIONS HOLDINGS LIMITED | ||||||||||||||||
| 7TH FL 50 BROADWAY | LONDON | UK | SW1H 0DB | 981468960 | HOLDING COMPANY | UK | EMAVANT SOLUTIONS LTD | C | 0 | |||||||
| EMAVANT SOLUTIONS LTD | ||||||||||||||||
| 7TH FL 50 BROADWAY | LONDON | UK | SW1H 0DB | 981490144 | HOLDING COMPANY | BD | ROIVANT SCIENCES LTD | C | 0 | |||||||
| ENZYME CORPORATION | ||||||||||||||||
| 475219560 | IT RELATED SERVICES | ROIVANT SCIENCES LTD | C | 0 | 611 GATEWAY BOULEVARD SUITE 120 | SAN FRANCISCO | CA | 94080 | DE | |||||||
| GENEVANT SCIENCES BIOVENTURES GMBH | ||||||||||||||||
| VIADUKTSTRASSE 8 | BASEL | SZ | 4051 | SCIENTIFIC R&D | SZ | GENEVANT SCIENCES GMBH | C | 0 | ||||||||
| GENEVANT SCIENCES CORPORATION | ||||||||||||||||
| 887 GRAND NORTHERN WAY | VANCOUVER | CA | 3L6 CA | 981486273 | SCIENTIFIC R&D | CA | GENEVANT SCIENCES HOLDINGS LIMITED | C | 0 | BRITISH COLUMBIA | ||||||
| GENEVANT SCIENCES GMBH | ||||||||||||||||
| VIADUKTSTRASSE 8 | BASEL | SZ | 4051 | 981468560 | SCIENTIFIC R&D | SZ | GENEVANT SCIENCES HOLDINGS LIMITED | C | 0 | |||||||
| GENEVANT SCIENCES HOLDINGS LIMITED | ||||||||||||||||
| 7TH FL 50 BROADWAY | LONDON | UK | SW1H 0DB | 981466897 | HOLDING COMPANY | UK | GENEVANT SCIENCES LTD | C | 0 | |||||||
| GENEVANT SCIENCES LTD | ||||||||||||||||
| 7TH FL 50 BROADWAY | LONDON | UK | SW1H 0DB | 371927500 | HOLDING COMPANY | BD | ROIVANT SCIENCES LTD | C | 0 | |||||||
| GENEVANT SCIENCES INC | ||||||||||||||||
| 824617869 | SCIENTIFIC R&D | GENEVANT SCIENCES HOLDINGS LIMITED | C | 0 | 245 MAIN ST 2ND FL | CAMBRIDGE | MA | 02142 | DE | |||||||
| HAYSTACK HEALTH HOLDINGS COMPANY | ||||||||||||||||
| 920427479 | HOLDING COMPANY | ROIVANT SCIENCES LTD | C | 0 | 151 W 42ND ST | NEW YORK | NY | 10036 | DE | |||||||
| HAYSTACK HEALTH COMPANY | ||||||||||||||||
| 920401356 | BIOTECHNOLOGY R&D | HAYSTACK HEALTH HOLDINGS COMPANY | C | 0 | 151 W 42ND ST | NEW YORK | NY | 10036 | DE | |||||||
| HEKAHEART HOLDINGS INC | ||||||||||||||||
| 932552859 | HOLDING COMPANY | ROIVANT SCIENCES LTD | C | 0 | 151 W 42ND ST | NEW YORK | NY | 10036 | DE | |||||||
| HEKAHEART INC | ||||||||||||||||
| 932585341 | SCIENTIFIC R&D | HEKAHEART HOLDINGS INC | C | 0 | 151 W 42ND ST | NEW YORK | NY | 10036 | DE | |||||||
| HEMAVANT SCIENCES GMBH | ||||||||||||||||
| VIADUKTSTRASSE 8 | BASEL | SZ | 4051 | SCIENTIFIC R&D | SZ | HEMAVANT SCIENCES HOLDINGS LIMITED | C | 0 | ||||||||
| HEMAVANT SCIENCES HOLDINGS LIMITED | ||||||||||||||||
| 7TH FL 50 BROADWAY | LONDON | UK | SW1H 0DB | 981578379 | HOLDING COMPANY | UK | HEMAVANT SCIENCES LTD | C | 0 | |||||||
| HEMAVANT SCIENCES LTD | ||||||||||||||||
| 7TH FL 50 BROADWAY | LONDON | UK | SW1H 0DB | 981577750 | HOLDING COMPANY | BD | ROIVANT SCIENCES LTD | C | 0 | |||||||
| HEMAVANT SCIENCES INC | ||||||||||||||||
| 874047801 | SCIENTIFIC R&D | HEMAVANT SCIENCES HOLDINGS LIMITED | C | 0 | 151 W 42ND ST | NEW YORK | NY | 10036 | DE | |||||||
| IMMUNO-020 HOLDINGS LIMITED | ||||||||||||||||
| 7TH FL 50 BROADWAY | LONDON | UK | SW1H 0DB | 981468547 | HOLDING COMPANY | UK | IMMUNO-020 LTD | C | 0 | |||||||
| IMMUNO-020 LTD | ||||||||||||||||
| 7TH FL 50 BROADWAY | LONDON | UK | SW1H 0DB | 981492723 | HOLDING COMPANY | BD | ROIVANT SCIENCES LTD | C | 0 | |||||||
| IMMUNOVANT SCIENCES GMBH | ||||||||||||||||
| VIADUKTSTRASSE 8 | BASEL | SZ | 4051 | 981470927 | SCIENTIFIC R&D | SZ | IMMUNOVANT SCIENCES HOLDINGS LIMITED | C | 0 | |||||||
| IMMUNOVANT SCIENCES HOLDINGS LIMITED | ||||||||||||||||
| 7TH FL 50 BROADWAY | LONDON | UK | SW1H 0DB | 981468959 | HOLDING COMPANY | UK | IMMUNOVANT SCIENCES LTD | C | 0 | |||||||
| IMMUNOVANT SCIENCES LTD | ||||||||||||||||
| 7TH FL 50 BROADWAY | LONDON | UK | SW1H 0DB | 981494848 | HOLDING COMPANY | BD | IMMUNOVANT INC | C | 0 | |||||||
| IMMUNOVANT TREASURY INC | ||||||||||||||||
| 882574422 | HOLDING COMPANY | IMMUNOVANT INC | C | 0 | 320 W 37TH ST FL 6 | NEW YORK | NY | 10018 | DE | |||||||
| IMMUNOVANT INC (FKA HEALTH SCIENCES ACQUISITIONS CORPORATION) | ||||||||||||||||
| 832771572 | HOLDING COMPANY | ROIVANT SCIENCES LTD | C | 0 | 320 W 37TH ST FL 6 | NEW YORK | NY | 10018 | DE | |||||||
| IMVT CORPORATION (FKA IMMUNOVANT INC ) | ||||||||||||||||
| 831251299 | SCIENTIFIC R&D | IMMUNOVANT SCIENCES HOLDINGS LIMITED | C | 0 | 320 W 37TH ST FL 6 | NEW YORK | NY | 10018 | DE | |||||||
| IZANA BIOSCIENCE LIMITED | ||||||||||||||||
| 7TH FL 50 BROADWAY | LONDON | UK | SW1H 0DB | HOLDING COMPANY | UK | KINEVANT LTD | C | 0 | ||||||||
| KINEVANT LTD | ||||||||||||||||
| 7TH FL 50 BROADWAY | LONDON | UK | SW1H 0DB | 981495584 | HOLDING COMPANY | BD | ROIVANT SCIENCES LTD | C | 0 | |||||||
| KINEVANT SCIENCES GMBH | ||||||||||||||||
| VIADUKTSTRASSE 8 | BASEL | SZ | 4051 | 981527962 | SCIENTIFIC R&D | SZ | KINEVANT SCIENCES HOLDINGS LIMITED | C | 0 | |||||||
| KINEVANT SCIENCES HOLDINGS LIMITED | ||||||||||||||||
| 7TH FL 50 BROADWAY | LONDON | UK | SW1H 0DB | 981527842 | HOLDING COMPANY | UK | KINEVANT SCIENCES LTD | C | 0 | |||||||
| KINEVANT SCIENCES LTD | ||||||||||||||||
| 7TH FL 50 BROADWAY | LONDON | UK | SW1H 0DB | 981494851 | HOLDING COMPANY | BD | KINEVANT LTD | C | 0 | |||||||
| KINEVANT SCIENCES INC | ||||||||||||||||
| 833172270 | SCIENTIFIC R&D | KINEVANT SCIENCES HOLDINGS LIMITED | C | 0 | 151 W 42ND ST | NEW YORK | NY | 10036 | DE | |||||||
| LYSOVANT SCIENCES GMBH | ||||||||||||||||
| VIADUKTSTRASSE 8 | BASEL | SZ | 4051 | 981527959 | SCIENTIFIC R&D | SZ | LYSOVANT SCIENCES HOLDINGS LIMITED | C | 0 | |||||||
| LYSOVANT SCIENCES HOLDINGS LIMITED | ||||||||||||||||
| 7TH FL 50 BROADWAY | LONDON | UK | SW1H 0DB | 981527858 | HOLDING COMPANY | UK | LYSOVANT SCIENCES LTD | C | 0 | |||||||
| LYSOVANT SCIENCES LTD | ||||||||||||||||
| 7TH FL 50 BROADWAY | LONDON | UK | SW1H 0DB | 981494841 | HOLDING COMPANY | BD | ROIVANT SCIENCES LTD | C | 0 | |||||||
| LYSOVANT SCIENCES INC | ||||||||||||||||
| 832733221 | SCIENTIFIC R&D | LYSOVANT SCIENCES HOLDINGS LIMITED | C | 0 | 151 W 42ND ST | NEW YORK | NY | 10036 | DE | |||||||
| METAVANT HOLDINGS LIMITED | ||||||||||||||||
| 7TH FL 50 BROADWAY | LONDON | UK | SW1H 0DB | 981470961 | HOLDING COMPANY | UK | METAVANT SCIENCES LTD | C | 0 | |||||||
| METAVANT SCIENCES GMBH | ||||||||||||||||
| VIADUKTSTRASSE 8 | BASEL | SZ | 4051 | 981497075 | SCIENTIFIC R&D | SZ | METAVANT HOLDINGS LIMITED | C | 0 | |||||||
| METAVANT SCIENCES LTD | ||||||||||||||||
| 7TH FL 50 BROADWAY | LONDON | UK | SW1H 0DB | 981463971 | HOLDING COMPANY | BD | ROIVANT SCIENCES LTD | C | 0 | |||||||
| MVANT THERAPEUTICS HOLDINGS INC | ||||||||||||||||
| 883237760 | HOLDING COMPANY | ROIVANT SCIENCES LTD | C | 0 | 151 W 42ND ST | NEW YORK | NY | 10036 | DE | |||||||
| MVANT THERAPEUTICS INC | ||||||||||||||||
| 883226473 | SCIENTIFIC R&D | MVANT THERAPEUTICS HOLDINGS INC | C | 0 | 151 W 42ND ST | NEW YORK | NY | 10036 | DE | |||||||
| ONCOPIA THERAPEUTICS INC DBA PROTEOVANT THERAPEUTICS INC | ||||||||||||||||
| 821993382 | SCIENTIFIC R&D | PROTEOVANT SCIENCES INC | C | 0 | 151 W 42ND ST | NEW YORK | NY | 10036 | DE | |||||||
| OPHTHOVANT HOLDINGS LIMITED | ||||||||||||||||
| 7TH FL 50 BROADWAY | LONDON | UK | SW1H 0DB | 981466918 | HOLDING COMPANY | UK | OPHTHOVANT SCIENCES LTD | C | 0 | |||||||
| OPHTHOVANT SCIENCES GMBH | ||||||||||||||||
| VIADUKTSTRASSE 8 | BASEL | SZ | 4051 | 981463954 | SCIENTIFIC R&D | SZ | OPHTHOVANT HOLDINGS LIMITED | C | 0 | |||||||
| OPHTHOVANT SCIENCES LTD | ||||||||||||||||
| 7TH FL 50 BROADWAY | LONDON | UK | SW1H 0DB | 981527389 | HOLDING COMPANY | BD | ROIVANT SCIENCES LTD | C | 0 | |||||||
| PHARMAVANT 10 INC | ||||||||||||||||
| 874143208 | HOLDING COMPANY | ROIVANT SCIENCES INC | C | 0 | 151 W 42ND ST | NEW YORK | NY | 10036 | DE | |||||||
| PHARMAVANT 13 INC | ||||||||||||||||
| 933705825 | SCIENTIFIC R&D | ROIVANT SCIENCES LTD | C | 0 | 151 W 42ND ST | NEW YORK | NY | 10036 | DE | |||||||
| PHARMAVANT 3 GMBH | ||||||||||||||||
| VIADUKTSTRASSE 8 | BASEL | SZ | 4051 | 981527951 | SCIENTIFIC R&D | SZ | PHARMAVANT 3 HOLDINGS LTD | C | 0 | |||||||
| PHARMAVANT 3 HOLDINGS LTD | ||||||||||||||||
| 7TH FL 50 BROADWAY | LONDON | UK | SW1H 0DB | 981527865 | HOLDING COMPANY | UK | KINEVANT LTD | C | 0 | |||||||
| PHARMAVANT 9 GMBH | ||||||||||||||||
| VIADUKTSTRASSE 8 | BASEL | SZ | 4051 | SCIENTIFIC R&D | SZ | PHARMAVANT 9 HOLDINGS LIMITED | C | 0 | ||||||||
| PHARMAVANT 9 HOLDINGS LIMITED | ||||||||||||||||
| 7TH FL 50 BROADWAY | LONDON | UK | SW1H 0DB | HOLDING COMPANY | UK | PHARMAVANT 9 LTD | C | 0 | ||||||||
| PHARMAVANT 9 LTD | ||||||||||||||||
| CLARENDON HOUSE 2 CHURCH ST | HAMILTON | BD | HM11 | HOLDING COMPANY | BD | ROIVANT SCIENCES LTD | C | 0 | ||||||||
| PRIMAVANT GMBH | ||||||||||||||||
| VIADUKTSTRASSE 8 | BASEL | SZ | 4051 | 981527980 | ALL OTHER PROFESSIONAL, SCIENTIFIC & TECHNICAL SERVICES | SZ | PRIMAVANT HOLDINGS LTD | C | 0 | |||||||
| PRIMAVANT HOLDINGS LTD | ||||||||||||||||
| 7TH FL 50 BROADWAY | LONDON | UK | SW1H 0DB | 981527870 | HOLDING COMPANY | UK | PRIMAVANT LTD | C | 0 | |||||||
| PRIMAVANT LTD | ||||||||||||||||
| CLARENDON HOUSE 2 CHURCH ST | HAMILTON | BD | HM11 | 981527381 | HOLDING COMPANY | BD | ROIVANT SCIENCES LTD | C | 0 | |||||||
| PRIOVANT HOLDINGS INC | ||||||||||||||||
| 871233821 | BIOTECHNOLOGY R&D | ROIVANT SCIENCES LTD | C | 0 | 151 W 42ND ST | NEW YORK | NY | 10036 | DE | |||||||
| PRIOVANT THERAPEUTICS INC | ||||||||||||||||
| 871508551 | BIOTECHNOLOGY R&D | PRIOVANT HOLDINGS INC | C | 0 | 151 W 42ND ST | NEW YORK | NY | 10036 | DE | |||||||
| PROTEOVANT SCIENCES INC | ||||||||||||||||
| 845089582 | HOLDING COMPANY | ROIVANT SCIENCES LTD | C | 0 | 151 W 42ND ST | NEW YORK | NY | 10036 | DE | |||||||
| PSIVANT THERAPEUTICS INC | ||||||||||||||||
| 883935036 | SCIENTIFIC R&D | ROIVANT DISCOVERY INC | C | 0 | 451 D STREET | BOSTON | MA | 02210 | DE | |||||||
| PULMOVANT INC | ||||||||||||||||
| 923322345 | SCIENTIFIC R&D | ROIVANT SCIENCES LTD | C | 0 | 451 D STREET | BOSTON | MA | 02210 | DE | |||||||
| RCAC HOLDINGS LIMITED | ||||||||||||||||
| 7TH FL 50 BROADWAY | LONDON | UK | SW1H 0DB | 981590079 | HOLDING COMPANY | UK | ROIVANT SCIENCES LTD | C | 0 | |||||||
| RESPIVANT SCIENCES GMBH | ||||||||||||||||
| VIADUKTSTRASSE 8 | BASEL | SZ | 4051 | 981463957 | SCIENTIFIC R&D | SZ | RESPIVANT SCIENCES HOLDINGS LTD | C | 0 | |||||||
| RESPIVANT SCIENCES HOLDINGS LTD | ||||||||||||||||
| 7TH FL 50 BROADWAY | LONDON | UK | SW1H 0DB | 981470825 | HOLDING COMPANY | UK | RESPIVANT SCIENCES LTD | C | 0 | |||||||
| RESPIVANT SCIENCES LTD | ||||||||||||||||
| 7TH FL 50 BROADWAY | LONDON | UK | SW1H 0DB | 981463960 | HOLDING COMPANY | BD | ROIVANT SCIENCES LTD | C | 0 | |||||||
| ROIVANT ASIA CELL THERAPY HOLDINGS LTD | ||||||||||||||||
| CLARENDON HOUSE 2 CHURCH ST | BERMUDA | BD | HM11 | HOLDING COMPANY | BD | ROIVANT SCIENCES LTD | C | 0 | ||||||||
| ROIVANT CHINA HOLDINGS LTD | ||||||||||||||||
| CLARENDON HOUSE 2 CHURCH ST | HAMILTON | BD | HM11 | 981459587 | HOLDING COMPANY | BD | ROIVANT SCIENCES LTD | C | 0 | |||||||
| ROIVANT DISCOVERY INC | ||||||||||||||||
| 862031998 | SCIENTIFIC R&D | ROIVANT SCIENCES INC | C | 0 | 451 D ST | BOSTON | MA | 02210 | DE | |||||||
| ROIVANT HEALTH STEALTH CO 3 HOLDINGS INC | ||||||||||||||||
| 921273943 | HOLDING COMPANY | ROIVANT SCIENCES LTD | C | 0 | 151 W 42ND ST | NEW YORK | NY | 10036 | DE | |||||||
| ROIVANT HEALTH STEALTH CO 3 INC | ||||||||||||||||
| 921270252 | HOLDING COMPANY | ROIVANT HEALTH STEALTH CO 3 HOLDINGS INC | C | 0 | 151 W 42ND ST | NEW YORK | NY | 10036 | DE | |||||||
| ROIVANT HEPATOLOGY GMBH | ||||||||||||||||
| VIADUKTSTRASSE 8 | BASEL | SZ | 4051 | 981527964 | SCIENTIFIC R&D | SZ | ROIVANT HEPATOLOGY HOLDINGS LIMITED | C | 0 | |||||||
| ROIVANT HEPATOLOGY HOLDINGS LIMITED | ||||||||||||||||
| 7TH FL 50 BROADWAY | LONDON | UK | SW1H 0DB | 981466920 | HOLDING COMPANY | UK | ROIVANT HEPATOLOGY LTD | C | 0 | |||||||
| ROIVANT HEPATOLOGY LTD | ||||||||||||||||
| 7TH FL 50 BROADWAY | LONDON | UK | SW1H 0DB | 981493148 | HOLDING COMPANY | BD | ROIVANT SCIENCES LTD | C | 0 | |||||||
| ROIVANT MS 2 LTD | ||||||||||||||||
| CLARENDON HOUSE 2 CHURCH ST | HAMILTON | BD | HM11 | HOLDING COMPANY | BD | ROIVANT SCIENCES LTD | C | 0 | ||||||||
| ROIVANT RHINE HOLDINGS INC | ||||||||||||||||
| 851830874 | INVESTMENTS | ROIVANT TREASURY HOLDINGS INC | C | 0 | 151 W 42ND ST | NEW YORK | NY | 10036 | DE | |||||||
| ROIVANT SCIENCES CANADA INC | ||||||||||||||||
| 1600-925 WEST GEORGIA ST | VANCOUVER | CA | V6C 3L2 | SCIENTIFIC R&D | CA | ROIVANT SCIENCES HOLDINGS LIMITED | C | 0 | BRITISH COLUMBIA | |||||||
| ROIVANT SCIENCES GMBH | ||||||||||||||||
| VIADUKTSTRASSE 8 | BASEL | SZ | 4051 | 981506527 | SCIENTIFIC R&D | SZ | ROIVANT SCIENCES HOLDINGS LIMITED | C | 0 | |||||||
| ROIVANT SCIENCES HOLDINGS LIMITED | ||||||||||||||||
| 7TH FL 50 BROADWAY | LONDON | UK | SW1H 0DB | 981468948 | HOLDING COMPANY | UK | ROIVANT SCIENCES LTD | C | 0 | |||||||
| ROIVANT SCIENCES IRELAND LIMITED | ||||||||||||||||
| ROCKTWIST HOUSE BLOCK 1 WESTERN BU | CLARE | EI | V14 FW97 | 981530399 | SCIENTIFIC R&D | EI | ROIVANT SCIENCES HOLDINGS LIMITED | C | 0 | CLARE | ||||||
| ROIVANT SCIENCES LTD | ||||||||||||||||
| 7TH FL 50 BROADWAY | LONDON | UK | SW1H 0DB | 981173944 | HOLDING COMPANY | BD | C | 0 | N/A | |||||||
| ROIVANT SCIENCES INC | ||||||||||||||||
| 465630757 | SCIENTIFIC R&D | ROIVANT SCIENCES HOLDINGS LIMITED | C | 0 | 151 W 42ND ST | NEW YORK | NY | 10036 | DE | |||||||
| ROIVANT TREASURY HOLDINGS INC | ||||||||||||||||
| 824789074 | SCIENTIFIC R&D | ROIVANT SCIENCES LTD | C | 0 | 151 W 42ND ST | NEW YORK | NY | 10036 | DE | |||||||
| ROIVANT TREASURY INC | ||||||||||||||||
| 824794439 | SCIENTIFIC R&D | ROIVANT TREASURY HOLDINGS INC | C | 0 | 151 W 42ND ST | NEW YORK | NY | 10036 | DE | |||||||
| SILICON TX HOLDINGS HK LIMITED | ||||||||||||||||
| UNIT 402 4TH FLOOR FAIRMONT HOUSE | ADMIRALTY | CH | HOLDING COMPANY | HK | ROIVANT MS 2 LTD | C | 0 | HONG KONG | ||||||||
| SINOVANT SCIENCES HK LIMITED | ||||||||||||||||
| 9/F THREE EXCHANGE SQUARE | CENTRAL HONG KONG | CH | HOLDING COMPANY | HK | ROIVANT CHINA HOLDINGS LTD | C | 0 | HONG KONG | ||||||||
| TELAVANT HOLDINGS INC | ||||||||||||||||
| 921042009 | HOLDING COMPANY | ROIVANT SCIENCES LTD | C | 0 | 1 DNA WAY MS 24 | SAN FRANCISCO | CA | 94080 | DE | |||||||
| TELAVANT INC | ||||||||||||||||
| 884301873 | SCIENTIFIC R&D | TELAVANT HOLDINGS INC | C | 0 | 1 DNA WAY MS 24 | SAN FRANCISCO | CA | 94080 | DE | |||||||
| VANTAI HOLDINGS INC | ||||||||||||||||
| 843434923 | HOLDING COMPANY | ROIVANT SCIENCES LTD | C | 0 | 151 W 42ND ST | NEW YORK | NY | 10036 | DE | |||||||
| VANTAI INC | ||||||||||||||||
| 843426285 | DATA ANALYTICS | VANTAI HOLDINGS INC | C | 0 | 151 W 42ND ST | NEW YORK | NY | 10036 | DE | |||||||
| ZEST DERMATOLOGY HOLDINGS INC | ||||||||||||||||
| 881717991 | HOLDING COMPANY | ROIVANT SCIENCES LTD | C | 0 | 2730 SAND HILL ROAD SUITE 120 | MENLO PARK | CA | 94025 | DE | |||||||
| ZEST DERMATOLOGY INC | ||||||||||||||||
| 881739718 | ADMINISTRATIVE SERVICES | ZEST DERMATOLOGY HOLDINGS INC | C | 0 | 2730 SAND HILL ROAD SUITE 120 | MENLO PARK | CA | 94025 | DE | |||||||
| Field | Value | IRS element (for citing) |
|---|---|---|
| Receipt Of Int Annts Rnts Rylts | 0 | ReceiptOfIntAnntsRntsRyltsInd |
| Gift Grnt Or Cap Contri To Oth Org | 0 | GiftGrntOrCapContriToOthOrgInd |
| Gift Grnt Cap Contri From Oth Org | 0 | GiftGrntCapContriFromOthOrgInd |
| Loans Or Guarantees To Other Org | 0 | LoansOrGuaranteesToOtherOrgInd |
| Loans Or Guarantees From Oth Org | Yes (1) | LoansOrGuaranteesFromOthOrgInd |
| Div Related Organization | 0 | DivRelatedOrganizationInd |
| Asset Sale To Other Org | 0 | AssetSaleToOtherOrgInd |
| Asset Purchase From Other Org | 0 | AssetPurchaseFromOtherOrgInd |
| Asset Exchange | 0 | AssetExchangeInd |
| Rental Of Facilities To Oth Org | 0 | RentalOfFacilitiesToOthOrgInd |
| Rental Of Fclts From Oth Org | 0 | RentalOfFcltsFromOthOrgInd |
| Perform Of Services For Oth Org | 0 | PerformOfServicesForOthOrgInd |
| Perform Of Services By Other Org | 0 | PerformOfServicesByOtherOrgInd |
| Sharing Of Facilities | Yes (1) | SharingOfFacilitiesInd |
| Paid Employees Sharing | Yes (1) | PaidEmployeesSharingInd |
| Reimbursement Paid To Other Org | 0 | ReimbursementPaidToOtherOrgInd |
| Reimbursement Paid By Other Org | 0 | ReimbursementPaidByOtherOrgInd |
| Transfer To Other Org | 0 | TransferToOtherOrgInd |
| Transfer From Other Org | 0 | TransferFromOtherOrgInd |
Transactions Related Org TransactionsRelatedOrgGrp
Other Organization Name OtherOrganizationName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | ROIVANT SCIENCES LTD | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Transaction Type | E | TransactionTypeTxt |
| Involved | $250,000 | InvolvedAmt |
| Method Of Amount Determination | FMV | MethodOfAmountDeterminationTxt |